CA3266555A1 - Composition pour le traitement d'une infection par le vih - Google Patents

Composition pour le traitement d'une infection par le vih

Info

Publication number
CA3266555A1
CA3266555A1 CA3266555A CA3266555A CA3266555A1 CA 3266555 A1 CA3266555 A1 CA 3266555A1 CA 3266555 A CA3266555 A CA 3266555A CA 3266555 A CA3266555 A CA 3266555A CA 3266555 A1 CA3266555 A1 CA 3266555A1
Authority
CA
Canada
Prior art keywords
composition
hiv infection
treating hiv
treating
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3266555A
Other languages
English (en)
Inventor
Yasuhiro Yasutomi
Tomotaka OKAMURA
Original Assignee
National Institutes of Biomedical Innovation Health and Nutrition
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institutes of Biomedical Innovation Health and Nutrition filed Critical National Institutes of Biomedical Innovation Health and Nutrition
Publication of CA3266555A1 publication Critical patent/CA3266555A1/fr
Pending legal-status Critical Current

Links

CA3266555A 2022-09-02 2023-09-01 Composition pour le traitement d'une infection par le vih Pending CA3266555A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022-140218 2022-09-02

Publications (1)

Publication Number Publication Date
CA3266555A1 true CA3266555A1 (fr) 2025-10-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP4103164A4 (fr) Composés de traitement d'infection à coronavirus
IL295677B1 (en) Tetracyclic compounds for the treatment of HIV infection
EP4157327A4 (fr) Compositions et méthodes permettant de prévenir et de traiter une infection par sars-cov-2
EP4213820A4 (fr) Méthodes et compositions pour traiter des infections virales
EP4093758A4 (fr) Méthodes et compositions de traitement et de prévention d'infections virales
CA3256727A1 (fr) Compositions pour le traitement de xlmtm
CA3266555A1 (fr) Composition pour le traitement d'une infection par le vih
EP4367086A4 (fr) Compositions et méthodes de traitement et de prévention d'infections virales
EP4161646A4 (fr) Compositions et procédés de traitement d'une infection virale
HK40084831A (en) Tetracyclic compounds for treating hiv infection
AU2022903797A0 (en) Compounds for treating viral infection
EP4167989A4 (fr) Composition pour le traitement d'infections virales
CA3273151A1 (fr) Composition de traitement
HK40089172A (en) Bacteriophage compositions for treating pseudomonas infection
HK40101531A (en) Methods and compositions for treating viral infection
HK40096243A (en) Compositions and methods for treating viral infection
HK40097509A (en) Compositions for preventing infection
HK40085866A (en) Bacteriophage compositions for treating staphylococcus infection
EP4106782A4 (fr) Compositions de bactériophages pour le traitement d'une infection à staphylococcus
HK40119443A (en) Compositions for treating xlmtm
HK40085824A (en) Methods and compositions for treating and preventing viral infection
AU2024364237A1 (en) Conjugates, compositions and methods for treating rsv infection
CA3308400A1 (fr) Conjugues, compositions et methodes de traitement d'une infection par le vrs
CA3266182A1 (fr) Composition pharmaceutique pour le traitement du lymphome
HK40116683A (en) Therapeutic compounds for hiv virus infection